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Lipopolysaccharide (LPS) as major constituent of Gram-
negative bacteria is known to elicit a rapid pro-inflamma-
tory primary response in immune cells. Multiple findings
indicate that monocytes next to its crucial function in the
early stage of LPS signaling might additionally play an
essential role in the resolution of systemic inflammatory
responses. We therefore compared gene expression pro-
files of short-term and long-term LPS-stimulated mono-
cytes. Surprisingly, we revealed an anti-inflammatory
gene expression program after long-term LPS treatment.
Blocking different signaling pathways revealed p38 MAP
kinase to be significantly involved in the regulation of this
anti-inflammatory program. Functional clustering analy-
sis showed that chromatin remodeling genes are signifi-
cantly overrepresented in the group of p38 MAP kinase-
dependent genes. To test whether epigenetic modifica-
tions cause transcriptional silencing in long-term LPS-
treated monocytes and whether this process is p38 MAP
kinase-dependent we performed chromatin-immunopre-
cipitations. We confirmed for pro-inflammatory genes an
increased trimethylation of histone 3 (H3K4me3) and
increased acetylation of histone 4 (AcH4) after 4 h LPS
treatment indicating increased transcription whereas after
16 h of LPS treatment AcH4 decreased. Blocking p38 MAP
kinase reversed the long-term LPS effect causing a strong
increase of AcH4 and methylation of K79 both indicators
of high transcriptional activity. Our results show that p38
MAP kinase contributes significantly to an anti-inflamma-
tory gene expression program in monocytes after long-
term LPS treatment. The application of p38 MAP kinase
inhibitors currently proposed as novel anti-inflammatory
agents might result in deleterious effects on innate
immune-regulatory mechanisms.
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